Blog

Feb 23, 2021

First-in-human clinical trial confirms HIV vaccine approach

Posted by in category: biotech/medical

A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, IAVI and Scripps Research announced today. The vaccine showed success in stimulating production of rare immune cells needed to start the process of generating antibodies against the fast-mutating virus; the targeted response was detected in 97 percent of participants who received the vaccine.

Comments are closed.